Brevilin A
Brevilin A has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 30, 2022: “Brevilin A enhances innate immunity and the resistance of oxidative stress in Caenorhabditis elegans via p38 MAPK pathway”.
See all 1 papers on brevilin A
At a glance
The findings reach worms or flies, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Model organisms1
What did studies of brevilin A find?
5Studies of brevilin A measured 5 outcomes, among them lifespan, oxidative stress and ROS signaling and pmk-1.
Lifespan
upin worms1
1 study
Lifespan
upin worms1
Brevilin A extends lifespan in worms.
Model organisms
Oxidative stress and ROS signaling
downin worms1
1 study
Oxidative stress and ROS signaling
downin worms1
Brevilin A protects against oxidative stress and ROS signaling in worms.
Model organisms
pmk-1
upin worms1
1 study
pmk-1
upin worms1
Brevilin A activates pmk-1 in worms.
Model organismsintestine
Bacterial burden
downin worms1
1 study
Bacterial burden
downin worms1
Brevilin A decreases bacterial burden in worms.
Model organismsintestine
Bacterial infection
downin worms1
1 study
Bacterial infection
downin worms1
Brevilin A protects against bacterial infection in worms.
Model organisms10 μM